Alpha DNA Investment Management »

Travere Therapeutics shares owned by Alpha DNA Investment Management

Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by Alpha DNA Investment Management from 13F filings

Historical chart of Alpha DNA Investment Management investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Alpha DNA Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Alpha DNA Investment Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $542k 70k 7.71

More positions owned by Alpha DNA Investment Management

Ishares Tr Russell 2000 Etf Put Option (IWM)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Microsoft Corporation (MSFT)
JPMorgan Chase & Co. (JPM)
Chubb (CB)
McDonald's Corporation (MCD)
Mondelez Intl Cl A (MDLZ)
Merck & Co (MRK)
Wal-Mart Stores (WMT)
Union Pacific Corporation (UNP)
Wells Fargo & Company (WFC)
Apple (AAPL)
Cigna Corp (CI)
Bank of America Corporation (BAC)
Nextera Energy (NEE)

View all positions for Alpha DNA Investment Management

Top funds holding Travere Therapeutics

BlackRock
Armistice Capital
Vanguard Group
Morgan Stanley
Rock Springs Capital Management
Deutsche Bank Aktiengesellschaft
Pictet Asset Management Holding SA
Millennium Management
Kynam Capital Management
D. E. Shaw & Co
Emerald Advisers
Bank of America Corporation
Finepoint Capital
Geode Capital Management
Emerald Mutual Fund Advisers, Trust

View all funds holding Travere Therapeutics